Paclitaxel Protein Bound Particles Albumin Bound Injection, Powder, Lyophilized, For Suspension
Product Images NDC 0517-4300

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paclitaxel Protein Bound Particles Albumin Bound (NDC 0517-4300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Paclitaxel Protein Bound Particles For Injectable 1)

Illustration showing a vial with a powder for suspension and a syringe drawing liquid from the vial. This instructional image is likely related to the preparation of an intravenous injection of Paclitaxel protein bound particles albumin bound.*

FDA Label Image

Structural Formula (Paclitaxel Protein Bound Particles For Injectable 2)

Chemical structure of Paclitaxel, shown in a two-dimensional molecular diagram illustrating its benzene rings, ester groups, and acetate substituents characteristic of the compound.*

FDA Label Image

Figure 1 (Paclitaxel Protein Bound Particles For Injectable 3)

A survival curve chart comparing the proportion of survival over time in months for three groups: Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) plus Gemcitabine, Gemcitabine alone, and a combined group. The x-axis shows time in months, and the y-axis shows the proportion of survival. Number of patients at risk is shown below the chart at multiple time points.*

FDA Label Image

Paclitaxel Vial Label (Paclitaxel Protein Bound Particles For Injectable 4)

Label for Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound) 100 mg per vial, single-dose vial for intravenous use only. The label includes usage warnings, storage instructions, and manufacturer information for American Regent, Inc.*

FDA Label Image

Printed Carton (Paclitaxel Protein Bound Particles For Injectable 5)

Packaging label for PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND 100 mg per vial, an injection powder lyophilized for suspension for intravenous use. The single-dose vial is manufactured by American Regent, Inc. The label includes dosage strength, usage instructions, warnings, and storage information along with a barcode and the NDC code 0517-4300.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.